GE Healthcare has licensed Computed Tomography (CT) organ dosimetry technology developed at Duke University. The development of the tool was led by Dr. W. Paul Segars and Dr. Ehsan Samei (Radiology). The technology will be incorporated into an organ dose module within GE’s DoseWatchTM, a digital informatics solution that automatically collects, monitors, and reports on radiation dose indices for diagnostic imaging exams. DoseWatch is used by healthcare providers around the world to reduce variation in practice, help ensure patient safety, and drive compliance with government regulations and accreditation requirements. The new tool will provide the CT study acquisition information for the organ dose calculation, as well as the machine-learning technology to accurately match a patient with his or her electronic counterpart. According to GE Sr. Medical Physicist, Dr. David Miller, “This is a big step towards accurate, personalized radiation dose for the CT patient. Doing organ dose right requires precise modeling of both the patient and the radiation field. The combination of GE and Duke technology will bring significant improvements in patient modeling, account for tube current modulation, and provide an estimation of dose to tissues outside the field of view.“